Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1|
De Mazière, C.
Van Vlierberghe, P.
|Citation:||Blood, 2020; 136(8):957-973|
|Publisher:||American Society of Hematology|
|Catherine L. Carmichael ... Benjamin T. Kile ... et al.|
|Abstract:||Modulators of epithelial-to-mesenchymal transition (EMT) have recently emerged as novel players in the field of leukemia biology. The mechanisms by which EMT modulators contribute to leukemia pathogenesis, however, remain to be elucidated. Here we show that overexpression of SNAI1, a key modulator of EMT, is a pathologically relevant event in human acute myeloid leukemia (AML) that contributes to impaired differentiation, enhanced self-renewal, and proliferation of immature myeloid cells. We demonstrate that ectopic expression of Snai1 in hematopoietic cells predisposes mice to AML development. This effect is mediated by interaction with the histone demethylase KDM1A/LSD1. Our data shed new light on the role of SNAI1 in leukemia development and identify a novel mechanism of LSD1 corruption in cancer. This is particularly pertinent given the current interest surrounding the use of LSD1 inhibitors in the treatment of multiple different malignancies, including AML.|
|Rights:||© 2020 by The American Society of Hematology|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.